Deregulation of CREB signalling is associated with several neurodegenerative diseases, for instance, Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and ALS.22, 24, 25, 26. Here, CREB1 is linked to neurodegenerative disease.